In the BioHarmony Drug Report Database

"Preview" Icon

Febuxostat

Uloric, Adenuric (febuxostat) is a small molecule pharmaceutical. Febuxostat was first approved as Uloric on 2008-04-21. It is used to treat gout in the USA. It has been approved in Europe to treat gout, gouty arthritis, and hyperuricemia. The pharmaceutical is active against xanthine dehydrogenase/oxidase. Uloric’s patents are valid until 2031-09-08 (FDA).

 

Trade Name

 

Adenuric
 

Common Name

 

febuxostat
 

ChEMBL ID

 

CHEMBL1164729
 

Indication

 

gout, gouty arthritis, hyperuricemia
 

Drug Class

 

Enzyme inhibitors: xanthine oxydase and xanthine

Image (chem structure or protein)

Febuxostat structure rendering